Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00676793 · ClinicalTrials.gov registry record · Phase 2
A Study of the Effect of Polyphenon E (Green Tea Extract) on Breast Cancer Progression
A Phase 2 study, sponsored by Louisiana State University Health Sciences Center Shreveport.
- Completed
- Registry status
- Phase 2
- Development phase
- 32
- Enrollment target
NCT00676793: Completed Phase 2 study, sponsored by Louisiana State University Health Sciences Center Shreveport.
NCT00676793 is a Phase 2 study that has completed, run by Louisiana State University Health Sciences Center Shreveport. The registered enrollment target is 32 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (76% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00676793, a Phase 2 study, has completed, sponsored by Louisiana State University Health Sciences Center Shreveport.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 32 participants
- Enrollment target
Study Summary
To see if an extract of green tea can affect certain markers of breast cancer and breast cancer progression in women with a recent biopsy positive for cancer and who are scheduled for surgery.
Primary Outcome
Change in serum VEGF from baseline to post treatment with polyphenon E.
Interventions
- DRUG Polyphenon E
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2004-05 |
| Est. Completion | 2013-07 |
| Phase | Phase 2 |
What the finished NCT00676793 record still lists
NCT00676793 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (76% lower).
The record links to 0 conditions, and to 1 intervention - of which Polyphenon E is the first listed.
NCT00676793 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00676793 about?
NCT00676793 is a clinical study titled "A Study of the Effect of Polyphenon E (Green Tea Extract) on Breast Cancer Progression". To see if an extract of green tea can affect certain markers of breast cancer and breast cancer progression in women with a recent biopsy positive for cancer and who are scheduled for surgery.
What is the current status of trial NCT00676793?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 32 participants. The study started on 2004-05. Estimated completion is 2013-07.
What interventions are being tested in trial NCT00676793?
The interventions under investigation include: Polyphenon E (DRUG).
Who is sponsoring clinical trial NCT00676793?
This trial is sponsored by Louisiana State University Health Sciences Center Shreveport, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00676793's enrollment target sits among peer trials
32 1563rd of 2000 higher than 423 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia